Objectives

After participating in this educational activity, attendees should be able to:
1. Describe common movement disorders.
2. Discuss treatments for various movement disorders, including VMAT2 inhibitors.
3. Critically review and evaluate some therapies in development.

Faculty

Samuel Frank, MD
Associate Professor
Harvard Medical School
Neurologist
Beth Israel Deaconess Medical Center

Faculty Disclosure
Dr. Frank receives grant/research for Neurocrine, Medtronic Fellowship grants

Session date: 
Wednesday, October 16, 2019 - 9:00am to 10:00am
Location: 
Baystate Medical Center
759 Chestnut Street
Springfield, MA 01199
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.